News

FDA Commissioner Marty Makary: Starting Process To Schedule "7-Hydroxymitragynine" Kratom Extract As Dangerous, Illegal Opioid
FDA Commissioner Marty Makary said at a press conference Tuesday that the federal government is beginning to process to ...
FDA Commissioner Makary: Ban Targets Synthetic Concentrated 7-OH, Not Naturally Occurring Trace Amounts
FDA Commissioner Marty Makary said at a press conference Tuesday that scheduling "7-Hydroxymitragynine" (7-OH) kratom extract ...
Beware: Synthetic kratom — 7-OH — is powering a new opioid crisis
Dangerous products are marketed as “kratom extract” or “enhanced kratom” and often disguised as candies, gummies and even ice ...
Opinion
When accepting or rejecting new drugs, the FDA will be transparent
‘Drug decision letters’ are being made public — which is good for manufacturers and patients.
Opinion
FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.
FDA Head Marty Makary on Food Dyes, Ultra-Processed Foods and the MAHA Agenda
The Food and Drug Administration commissioner reveals what health officials are prioritizing in a forthcoming report on ...
STAT4h
Vinay Prasad, a powerful FDA official, departs after controversy over rare disease drug
Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial ...
American Kratom Association Praises Secretary Kennedy and Commissioner Makary for Bold Action to Recommend Scheduling of Dangerous 7-OH Products
Secretary Kennedy and Commissioner Makary have shown exceptional leadership in confronting one of the most urgent public ...
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
STAT22h
How the FDA can score quick wins on transparency
Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...
FDA weighs warning labels on antidepressants for pregnant people despite safety consensus
The Food and Drug Administration is considering adding warning labels to antidepressants for people who are pregnant, despite ...